C237-0252 Screening compound: 4-(4-benzylpiperazin-1-yl)-N-[2-(3,5-dimethylpiperidin-1-yl)-4-methylquinolin-6-yl]-4-oxobutanamide

C237-0252 Screening compound: 4-(4-benzylpiperazin-1-yl)-N-[2-(3,5-dimethylpiperidin-1-yl)-4-methylquinolin-6-yl]-4-oxobutanamide
C237-0252 Screening compound: 4-(4-benzylpiperazin-1-yl)-N-[2-(3,5-dimethylpiperidin-1-yl)-4-methylquinolin-6-yl]-4-oxobutanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C237-0252
4-(4-benzylpiperazin-1-yl)-N-[2-(3,5-dimethylpiperidin-1-yl)-4-methylquinolin-6-yl]-4-oxobutanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C237-0252

Molecular Formula

C32H41N5O2 (C32 H41 N5 O2)

Compound Name

4-(4-benzylpiperazin-1-yl)-N-[2-(3,5-dimethylpiperidin-1-yl)-4-methylquinolin-6-yl]-4-oxobutanamide

IUPAC name

4-(4-benzylpiperazin-1-yl)-N-[2-(35-dimethylpiperidin-1-yl)-4-methylquinolin-6-yl]-4-oxobutanamide

SMILES

CC(CC(C)C1)CN1c1cc(C)c(cc(cc2)NC(CCC(N3CCN(Cc4ccccc4)CC3)=O)=O)c2n1

InChI

InChI=1S/C32H41N5O2/c1-23-17-24(2)21-37(20-23)30-18-25(3)28-19-27(9-10-29(28)34-30)33-31(38)11-12-32(39)36-15-13-35(14-16-36)22-26-7-5-4-6-8-26/h4-10,18-19,23-24H,11-17,20-22H2,1-3H3,(H,33,38)

InChI Key

ZTCKQQLMVUILFT-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14733793

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

527.71

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

5.096

Distribution Coefficient, logD

5.063

Water Solubility, LogSw

-4.96

Polar Surface Area

54.163

Acid Dissociation Constant (pKa)

11.10

Base Dissociation Constant (pKb)

6.30

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

46.90

C237-0252 in Drug Discovery

Included in Screening Libraries

CNS Targets (44014 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system

References: we are preparing a list of scientific research reports with C237-0252 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C237-0252?
Check Price and Availability of C237-0252, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C237-0252 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C237-0252
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C237-0252
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C237-0252 available by request